This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA832125; GEO: GSE201525 |
| Type | Umbrella project |
| Publications | Marks ZRC et al., "Interferon-ε is a tumour suppressor and restricts ovarian cancer.", Nature, 2023 Aug;620(7976):1063-1070 |
| Submission | Registration date: 26-Apr-2022
Hudson Institute of Medical Research |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 72 |
| Publications |
| PubMed | 1 |
| Other datasets |
| BioSample | 72 |
| GEO DataSets | 4 |
GEO Data Details| Parameter | Value |
|---|
| Data volume, Spots | 1511424 |
| Data volume, Processed Mbytes | 26 |
| Data volume, Supplementary Mbytes | 78 |
| Parameter | Value |
|---|
| Data volume, Gbases | 115 |
| Data volume, Mbytes | 48754 |
Investigation of the anti-tumour properties of interferon epsilon in high grade serous ovarian cancer encompasses the following 3 sub-projects:
| Project Type | Number of Projects |
| Transcriptome or Gene expression | 3 |
BioProject
accession | Organism | Title |
|---|
| PRJNA830890 | Homo sapiens | Investigation of the anti-tumour properties of interferon epsilon in high grade serous ovarian cancer in vivo. (Hudson Institute of Medical...) | | PRJNA830905 | Mus musculus | Investigation of the direct activity of interferon epsilon on ID8 ovarian cancer cells in vitro. (Hudson Institute of Medical...) | | PRJNA889445 | Mus musculus | Investigation of the direct activity of type I interferon on Ifnar1 KO ID8 ovarian cancer cells in vitro. (Hudson Institute of Medical...) |
|